We serve Chemical Name:1-methylsulfonylpiperidin-4-ol CAS:141482-19-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-methylsulfonylpiperidin-4-ol
CAS.NO:141482-19-1
Synonyms:4-hydroxy-1-(methanesulfonyl)-piperidine;N-(methanesulfonyl)-4-piperidinol;4-hydroxy-1-methylsulfonylpiperidine;1-(Methylsulfonyl)piperidin-4-ol;1-methanesulphonyl-piperidin-4-ol;1-(methylsulfonyl)-4-piperidinol
Molecular Formula:C6H13NO3S
Molecular Weight:179.23700
HS Code:2935009090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:65.99000
Exact Mass:179.06200
LogP:0.42140
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-hydroxy-1-(methanesulfonyl)-piperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(methylsulfonyl)-4-piperidinol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(methylsulfonyl)-4-piperidinol Use and application,1-methanesulphonyl-piperidin-4-ol technical grade,usp/ep/jp grade.
Related News: I look forward to working alongside such an ambitious team who are passionate about using cutting-edge technology to solve the health issues of the future and meet the needs of pharma and biotech companies across the globe.” (-)-(1S,2S,4R)-7,7-dimethoxynorbornan-2-endo-ol manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 3α,7-dimethoxy-crinan-2α-ol suppliers The study also found that the inhaled version of the vaccine did not cause serious side effects, demonstrating an encouraging safety profile in the early-stage trial. 1,4,7,10-tetraazacyclododecane-4,7,10-triacetic-1-(methyl[(4-aminophenyl)methyl]phosphinic acid) vendor & factory.
